LUCD · Forms 3, 4, 5
Insider trades at Lucid Diagnostics Inc.
No open-market insider buys or sells at Lucid Diagnostics Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Lucid Diagnostics Inc. (LUCD) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Lucid Diagnostics Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Dennis Matheis | Director | Buy | 245,000 | $1.00 | $245K | Form 4 | |
| Victoria Tou-ho Lee | Chief Medical Officer | Became an insider (Form 3) | Form 3 | ||||
| Lishan Aklog | Chief Executive Officer | Award | 2,170,000 | Form 4 | |||
| Dennis Matheis | Director | Award | 123,000 | Form 4 | |||
| Debra White | Director | Award | 123,000 | Form 4 | |||
| Ronald M Sparks | Director | Award | 123,000 | Form 4 | |||
| Jacque J Sokolov | Director | Award | 123,000 | Form 4 | |||
| John R Palumbo | Director | Award | 123,000 | Form 4 | |||
| Stanley Lapidus | Director | Award | 123,000 | Form 4 | |||
| James L Cox | Director | Award | 123,000 | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.